Navigation Links
BD to Present at Investor Healthcare Conferences
Date:6/1/2009

FRANKLIN LAKES, N.J., June 1 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it would present at the following investor healthcare conferences in June:

        Goldman Sachs 30th Annual Global Healthcare Conference
        June 10, 2009
        11:40 a.m. EDT

        8th Annual Needham Life Sciences Conference
        June 11, 2009
        10:00 a.m. EDT

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Avicena Group to Present at Noble Financial Conference
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CEL-SCI to Present at the Noble Financial Conference
7. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
8. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
9. Strategic Diagnostics Updates Roth Conference Presentation Time
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Daveys, the GLOBALS, ,and PM360 Pharma Choice Awards Programs. ... ... Chicago-based full-service healthcare communications agency Goble & Associates, Inc. (G&A) ... exceptional creative and interactive work. , , ,THE RX CLUB ... of Excellence for the following creative work: Hospira LifeShield ad ...
(Date:12/16/2009)... by scientists at the University of East Anglia (UEA) ... domestic or agricultural waste to generate clean electricity. , ... of the National Academy of Sciences (PNAS), the ... by which some bacteria survive by ,breathing rocks,. , ... development of new microbe-based technologies such as fuel cells, ...
(Date:12/16/2009)... Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading ... that it will be launching the Human MicroRNA ... using its SmartChip(TM) Real-Time PCR System. The ... microRNA panel of 885 microRNAs on a single ... the use of its proprietary SmartChip Real-Time PCR ...
(Date:12/16/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, according to responses from ... briakinumab (both interleukin inhibitors) will capture 22 percent ... drug market for moderate to severe psoriasis. Among ... capturing nearly three times as much patient share ...
Breaking Biology Technology:Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3
... InterMune, Inc.,(Nasdaq: ITMN ) today announced results from ... The company also provided 2008,financial guidance and milestones for its ... InterMune reported a net loss for the fourth quarter ... a net loss of $21.5 million, or,$0.64 per share, in ...
... Feb. 7 LifeCell Corporation,(Nasdaq: LIFC ), today ... due to the final settlement of a claim that ... is expected to reduce,diluted net income per share by ... in 2008, since the Company,s 2007,financial statements were not ...
... ATLANTA, Feb. 7 CryoLife, Inc., (NYSE: ... tissue processing company, today announced,that it has ... Drug Administration,(FDA) for its CryoValve(R) SG pulmonary ... SynerGraft technology. CryoLife,s proprietary,SynerGraft technology is designed ...
Other Biology Technology:InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 2InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 3InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 4InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 5InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 6InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 7InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 8InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 9InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 10InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 11LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 3
(Date:12/16/2009)... Tom Bowman, an expert in communicating scientific issues to ... developed a series of graphics that translate key figures ... report for public audiences. These new graphics provide non-experts ... make informed decisions about climate change risks and opportunities. ... to clearly and accurately communicate findings in the IPCC ...
(Date:12/16/2009)... GestureTek Inc. today announced the launch of ... portable, plug and play interactive projection display ... promotions. GestureTek is the inventor and holder ... recognition technology for interactive display, presentation and ... CUBE has TUV, CE, CSA and EMI ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...
Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 1Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 2Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 3Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 4Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 5Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 6Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 7Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 8Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update 5988 9Fast Eating Limits Gut Hormones That Induce Fullness 60704 1Fast Eating Limits Gut Hormones That Induce Fullness 60704 2Shorter More Intense Radiation OK for Some Breast Cancers 60701 1Shorter More Intense Radiation OK for Some Breast Cancers 60701 2Shorter More Intense Radiation OK for Some Breast Cancers 60701 3
... Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) ... to silence a mutated gene that causes inherited cases ... onset and the progression rate of the fatal motor ... April issue of Nature Medicine, and in the journal's ...
... (MUHC) in Montreal is pleased to announce the first successful ... by Professor Seang Lin Tan, Chair of the Department of ... McGill Reproductive Centre at the MUHC in Montreal confirmed the ... 29. "We are the first in-vitro fertilization (IVF) Centre in ...
... harmful chemicals and drugs during critical developmental periods early ... respond to the female hormone estrogen. This genetic reprogramming ... a disease actually develop the disease. , The new ... to uterine tumors also receive an early-life exposure to ...
Other Biology News:Silence the gene, save the cell: RNA interference as promising therapy for ALS 2Silence the gene, save the cell: RNA interference as promising therapy for ALS 3First frozen egg baby born in Canada 2First frozen egg baby born in Canada 3Harmful chemicals may reprogram gene response to estrogen 2Harmful chemicals may reprogram gene response to estrogen 3
Request Info...
1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...
... bioinformatics software that has changed the way ... design of BioNumerics allows for integration and ... data employed for the characterization of organisms ... protein gels, HPLC, VNTR, MLST, SNP, fatty ...
Request Info...
Biology Products: